You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
15 November 2019
Sanofi Consumer Healthcare has an option on technology from ResApp Health, which is developing smartphone applications for the diagnosis and management of respiratory disease.
15 November 2019
The new company formed from the planned combination of Mylan and Pfizer’s Upjohn business will be called Viatris.
15 November 2019
Walgreens Boots Alliance (WBA) may go private, the Amazon Pharmacy name has made an appearance, and Vitamin Shoppe has released financial results.
15 November 2019
Abbott, Unilever, the US Consumer Healthcare Products Association (CHPA) and Teva Pharmaceutical have all announced people changes.
12 November 2019
Walgreens Boots Alliance (WBA) plans to launch a health and beauty retail business in Indonesia through a partnership with local lifestyle retailer PT Mitra Adiperkasa (MAP).
11 November 2019
Sweden is reverse-switching oral medicines containing diclofenac from non-prescription to prescription-only status with effect from 1 June 2020.
8 November 2019
Bayer's Consumer Health division reported worldwide sales up by 3.7% on a currency- and portfolio-adjusted basis to EUR1.29 billion (USD1.41 billion) in the third quarter of 2019. Werner Baumann, Bayer's chief executive officer, said the team was “continuing to make good progress in turning around t...
8 November 2019
Sanofi's Consumer Healthcare business reported worldwide sales up by 0.4% at constant exchange rates in the third quarter of 2019. The company said growth had been curbed by a voluntary recall of Zantac, non-core brand divestments, and tightening regulatory requirements, particularly in Europe.
7 November 2019
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 25% at constant exchange rates in the third quarter of 2019, following consolidation of Pfizer’s Consumer Healthcare products.
5 November 2019
Stada Arzneimittel is acquiring Takeda’s OTC portfolio in Russia and the Commonwealth of Independent States (CIS) in a deal worth USD660 million. The deal comes a day after the German company announced it was purchasing Czech consumer healthcare firm Walmark.